Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Retractable Technologies (RVP) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Retractable Technologies (RVP) over the last 12 years, with Q3 2025 value amounting to $163000.0.

  • Retractable Technologies' Asset Writedowns and Impairment rose 136464.43% to $163000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $908195.0, marking a year-over-year increase of 5419.51%. This contributed to the annual value of $571682.0 for FY2024, which is 881.39% down from last year.
  • According to the latest figures from Q3 2025, Retractable Technologies' Asset Writedowns and Impairment is $163000.0, which was up 136464.43% from $601000.0 recorded in Q2 2025.
  • In the past 5 years, Retractable Technologies' Asset Writedowns and Impairment registered a high of $601000.0 during Q2 2025, and its lowest value of -$12889.0 during Q3 2024.
  • For the 4-year period, Retractable Technologies' Asset Writedowns and Impairment averaged around $176051.8, with its median value being $153542.0 (2021).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 11572.33% in 2024, then skyrocketed by 136464.43% in 2025.
  • Retractable Technologies' Asset Writedowns and Impairment (Quarter) stood at $3605.0 in 2021, then soared by 4737.53% to $174393.0 in 2023, then dropped by 9.93% to $157084.0 in 2024, then rose by 3.77% to $163000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $163000.0 for Q3 2025, versus $601000.0 for Q2 2025 and $157084.0 for Q4 2024.